Stay updated with breaking news from Adi Raviv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on August 24, 2023 The Annual General Meeting of Shareholders of BiondVax Pharmaceuticals Ltd. will...
/PRNewswire/ -- Elbit Systems Ltd: is marking 20 years of operating the sixteen GROP G-120-AI aircraft fleet of the Israeli Air Force (IAF) that was...
Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing, commercialization and clinical translation of...
This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022.
Mirror Biologics, Inc. Announces Appointment of Interim CEO Tampa, FL, May 12, 2021 --(PR.com)-- Mirror Biologics, Inc., a clinical stage biopharmaceutical company developing next generation immunotherapy treatments for cancer and infectious diseases, announces the appointment of Adi Raviv as interim Chief Executive Officer and member of the Board of Directors. "Adi brings a depth of corporate, capital market and financial experience that is a perfect complement to the scientific expertise and later stage clinical assets brought to the Company by Mirror’s founding team," said Dr. Michael ...